Asset Management
Compare Stocks
2 / 10Stock Comparison
AMP vs MET
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Life
AMP vs MET — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management | Insurance - Life |
| Market Cap | $45.77B | $52.27B |
| Revenue (TTM) | $18.91B | $76.13B |
| Net Income (TTM) | $3.56B | $3.38B |
| Gross Margin | 50.4% | 25.6% |
| Operating Margin | 25.5% | 6.1% |
| Forward P/E | 10.8x | 8.2x |
| Total Debt | $5.86B | $20.18B |
| Cash & Equiv. | $10.10B | $22.03B |
AMP vs MET — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ameriprise Financia… (AMP) | 100 | 339.3 | +239.3% |
| MetLife, Inc. (MET) | 100 | 222.6 | +122.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMP vs MET
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AMP is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 15 yrs, beta 1.12, yield 6.6%
- 459.2% 10Y total return vs MET's 156.8%
- Beta 1.12, yield 6.6%, current ratio 7.87x
MET carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 10.2%, EPS growth -19.2%, 3Y rev CAGR 4.3%
- Lower volatility, beta 1.09, Low D/E 69.8%, current ratio 0.65x
- 10.2% revenue growth vs AMP's 5.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.2% revenue growth vs AMP's 5.2% | |
| Value | Lower P/E (8.2x vs 10.8x) | |
| Quality / Margins | 18.8% margin vs MET's 4.4% | |
| Stability / Safety | Beta 1.09 vs AMP's 1.12, lower leverage | |
| Dividends | 6.6% yield, 15-year raise streak, vs MET's 2.8% | |
| Momentum (1Y) | +7.9% vs AMP's +1.3% | |
| Efficiency (ROA) | 1.9% ROA vs MET's 0.5%, ROIC 31.3% vs 13.1% |
AMP vs MET — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AMP vs MET — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AMP leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
MET is the larger business by revenue, generating $76.1B annually — 4.0x AMP's $18.9B. AMP is the more profitable business, keeping 18.8% of every revenue dollar as net income compared to MET's 4.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $18.9B | $76.1B |
| EBITDAEarnings before interest/tax | $4.8B | $5.7B |
| Net IncomeAfter-tax profit | $3.6B | $3.4B |
| Free Cash FlowCash after capex | $2.9B | $18.1B |
| Gross MarginGross profit ÷ Revenue | +50.4% | +25.6% |
| Operating MarginEBIT ÷ Revenue | +25.5% | +6.1% |
| Net MarginNet income ÷ Revenue | +18.8% | +4.4% |
| FCF MarginFCF ÷ Revenue | +15.3% | +23.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +29.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -1.0% | -34.3% |
Valuation Metrics
MET leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 13.1x trailing earnings, AMP trades at a 22% valuation discount to MET's 16.7x P/E. On an enterprise value basis, AMP's 8.2x EV/EBITDA is more attractive than MET's 8.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $45.8B | $52.3B |
| Enterprise ValueMkt cap + debt − cash | $41.5B | $50.4B |
| Trailing P/EPrice ÷ TTM EPS | 13.07x | 16.70x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.82x | 8.19x |
| PEG RatioP/E ÷ EPS growth rate | 0.54x | — |
| EV / EBITDAEnterprise value multiple | 8.24x | 8.81x |
| Price / SalesMarket cap ÷ Revenue | 2.42x | 0.68x |
| Price / BookPrice ÷ Book value/share | 6.99x | 1.84x |
| Price / FCFMarket cap ÷ FCF | 15.82x | 2.89x |
Profitability & Efficiency
AMP leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
AMP delivers a 58.1% return on equity — every $100 of shareholder capital generates $58 in annual profit, vs $12 for MET. MET carries lower financial leverage with a 0.70x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMP's 0.90x. On the Piotroski fundamental quality scale (0–9), MET scores 8/9 vs AMP's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +58.1% | +11.9% |
| ROA (TTM)Return on assets | +1.9% | +0.5% |
| ROICReturn on invested capital | +31.3% | +13.1% |
| ROCEReturn on capital employed | +2.6% | +1.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 8 |
| Debt / EquityFinancial leverage | 0.90x | 0.70x |
| Net DebtTotal debt minus cash | -$4.2B | -$1.8B |
| Cash & Equiv.Liquid assets | $10.1B | $22.0B |
| Total DebtShort + long-term debt | $5.9B | $20.2B |
| Interest CoverageEBIT ÷ Interest expense | 14.82x | 5.39x |
Total Returns (Dividends Reinvested)
AMP leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMP five years ago would be worth $19,129 today (with dividends reinvested), compared to $13,534 for MET. Over the past 12 months, MET leads with a +7.9% total return vs AMP's +1.3%. The 3-year compound annual growth rate (CAGR) favors AMP at 18.9% vs MET's 17.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -3.1% | +0.5% |
| 1-Year ReturnPast 12 months | +1.3% | +7.9% |
| 3-Year ReturnCumulative with dividends | +68.0% | +61.5% |
| 5-Year ReturnCumulative with dividends | +91.3% | +35.3% |
| 10-Year ReturnCumulative with dividends | +459.2% | +156.8% |
| CAGR (3Y)Annualised 3-year return | +18.9% | +17.3% |
Risk & Volatility
MET leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MET is the less volatile stock with a 1.09 beta — it tends to amplify market swings less than AMP's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MET currently trades 95.8% from its 52-week high vs AMP's 86.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 1.09x |
| 52-Week HighHighest price in past year | $550.18 | $83.64 |
| 52-Week LowLowest price in past year | $422.37 | $67.33 |
| % of 52W HighCurrent price vs 52-week peak | +86.4% | +95.8% |
| RSI (14)Momentum oscillator 0–100 | 58.6 | 66.3 |
| Avg Volume (50D)Average daily shares traded | 621K | 3.5M |
Analyst Outlook
AMP leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates AMP as "Buy" and MET as "Buy". Consensus price targets imply 20.4% upside for MET (target: $97) vs 10.6% for AMP (target: $526). For income investors, AMP offers the higher dividend yield at 6.61% vs MET's 2.83%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $525.80 | $96.50 |
| # AnalystsCovering analysts | 22 | 33 |
| Dividend YieldAnnual dividend ÷ price | +6.6% | +2.8% |
| Dividend StreakConsecutive years of raises | 15 | 13 |
| Dividend / ShareAnnual DPS | $31.41 | $2.27 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.6% | +7.4% |
AMP leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MET leads in 2 (Valuation Metrics, Risk & Volatility).
AMP vs MET: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is AMP or MET a better buy right now?
For growth investors, MetLife, Inc.
(MET) is the stronger pick with 10. 2% revenue growth year-over-year, versus 5. 2% for Ameriprise Financial, Inc. (AMP). Ameriprise Financial, Inc. (AMP) offers the better valuation at 13. 1x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate Ameriprise Financial, Inc. (AMP) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMP or MET?
On trailing P/E, Ameriprise Financial, Inc.
(AMP) is the cheapest at 13. 1x versus MetLife, Inc. at 16. 7x. On forward P/E, MetLife, Inc. is actually cheaper at 8. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AMP or MET?
Over the past 5 years, Ameriprise Financial, Inc.
(AMP) delivered a total return of +91. 3%, compared to +35. 3% for MetLife, Inc. (MET). Over 10 years, the gap is even starker: AMP returned +459. 2% versus MET's +156. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMP or MET?
By beta (market sensitivity over 5 years), MetLife, Inc.
(MET) is the lower-risk stock at 1. 09β versus Ameriprise Financial, Inc. 's 1. 12β — meaning AMP is approximately 3% more volatile than MET relative to the S&P 500. On balance sheet safety, MetLife, Inc. (MET) carries a lower debt/equity ratio of 70% versus 90% for Ameriprise Financial, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AMP or MET?
By revenue growth (latest reported year), MetLife, Inc.
(MET) is pulling ahead at 10. 2% versus 5. 2% for Ameriprise Financial, Inc. (AMP). On earnings-per-share growth, the picture is similar: Ameriprise Financial, Inc. grew EPS 10. 0% year-over-year, compared to -19. 2% for MetLife, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMP or MET?
Ameriprise Financial, Inc.
(AMP) is the more profitable company, earning 18. 8% net margin versus 4. 4% for MetLife, Inc. — meaning it keeps 18. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMP leads at 25. 5% versus 6. 0% for MET. At the gross margin level — before operating expenses — AMP leads at 50. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMP or MET more undervalued right now?
On forward earnings alone, MetLife, Inc.
(MET) trades at 8. 2x forward P/E versus 10. 8x for Ameriprise Financial, Inc. — 2. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MET: 20. 4% to $96. 50.
08Which pays a better dividend — AMP or MET?
All stocks in this comparison pay dividends.
Ameriprise Financial, Inc. (AMP) offers the highest yield at 6. 6%, versus 2. 8% for MetLife, Inc. (MET).
09Is AMP or MET better for a retirement portfolio?
For long-horizon retirement investors, Ameriprise Financial, Inc.
(AMP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 12), 6. 6% yield, +459. 2% 10Y return). Both have compounded well over 10 years (AMP: +459. 2%, MET: +156. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMP and MET?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.